|
Hot Stocks
| |
|
Initiation
| ShowHide Related Items >><< CASY Casey's General Stores - 06/27/22
- Casey's General Stores appoints Donthi to board of directors
- 06/07/22
- Casey's General Stores sees FY23 same-store inside sales up 4%-6%
- 06/07/22
- Casey's General Stores raises quarterly dividend 9% to 38c per share
- 04/21/22
- Casey's General Stores provides business update ahead of NDR
CASY Casey's General Stores - 07/18/22 Benchmark
- Benchmark starts Casey's General Stores at Buy, cites proven growth model
- 07/18/22 Benchmark
- Casey's General Stores initiated with a Buy at Benchmark
- 06/22/22 Deutsche Bank
- Casey's General Stores price target lowered to $255 from $259 at Deutsche Bank
- 06/08/22 RBC Capital
- Casey's General Stores price target lowered to $238 from $250 at RBC Capital
CASY Casey's General Stores - 06/07/22
- Casey's General Stores reports Q4 EPS $1.60, consensus $1.59
- 03/08/22
- Casey's General Stores reports Q3 EPS $1.71, consensus $1.45
CASY Casey's General Stores - 05/25/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Periodicals
| ShowHide Related Items >><< - 08/16/22
- WWE announces record first-day ticket sales for WrestleMania 39
- 08/16/22
- WWE raises FY22 adjusted OIBDA view to $370M-$385M from $360M-$375M
- 08/16/22
- WWE sees Q3 adjusted OIBDA $70M-$80M
- 08/16/22
- WWE: Probe of Vince McMahon 'substantially complete'
- 06:48 Today Benchmark
- WWE price target raised to $83 from $80 at Benchmark
- 06:25 Today Barclays
- Barclays ups WWE target but says company sale unlikely
- 07/26/22 Benchmark
- WWE price target raised to $80 from $71 at Benchmark
- 07/25/22 Loop Capital
- Loop Capital upgrades WWE to Buy on rising likelihood of company sale
- 08/16/22
- WWE reports Q2 adjusted EPS 59c vs. 34c last year
- 07/25/22
- WWE reports preliminary Q2 revenue $328M, consensus $311.84M
- 05/05/22
- WWE sees Q2 adjusted OIBDA $80M-$90M
- 05/05/22
- WWE reports Q1 EPS 77c, consensus 61c
- 07/08/22
- WWE's Vince McMahon paid over $12M to suppress misconduct claims, WSJ says
- 07/01/22
- WWE signs multi-event agreement with Logan Paul, ESPN reports
- 06/15/22
- WWE board investigating $3M 'hush pact' settlement by CEO, WSJ says
- 04/07/22
- Formula 1, WWE could be acquisition targets for streaming companies, CNBC says
- 08/16/22
- What You Missed On Wall Street On Tuesday
- 08/16/22
- What You Missed On Wall Street This Morning
- 07/25/22
- What You Missed On Wall Street On Monday
- 07/25/22
- What You Missed On Wall Street This Morning
|
|
Earnings
| ShowHide Related Items >><< - 03/16/22
- America's Car-Mart appoints Brian Stone as EVP, procurement, inventory
- 04/06/22 BofA
- America's Car-Mart double-downgraded to Underperform at BofA
- 04/06/22 BofA
- America's Car-Mart downgraded to Underperform from Buy at BofA
- 05/23/22
- America's Car-Mart reports Q4 EPS $4.01, consensus $3.10
- 04/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
On The Fly
| ShowHide Related Items >><< - 16:14 Today
- Wolfspeed sees 2026 revenue outlook up 30%-40% from prior forecast
- 16:09 Today
- Wolfspeed jumps 12% to $95.59 after above-consensus Q4 earnings and guidance
- 05/09/22
- Wolfspeed, Rhombus Energy collaborate for faster EV charging infrastructure
- 04/25/22
- Wolfspeed says Lucid integrates Silicon Carbide solutions into Lucid Air
- 17:24 Today
- Cisco expects continued high levels of order backlog
- 16:46 Today
- Cisco says cancellations below pre-pandemic levels
- 16:09 Today
- Cisco sees Q1 adjusted gross margin 63%-64%
- 16:08 Today
- Cisco CEO says full year product orders, backlog at 'record highs'
KEYS Keysight Technologies - 08/15/22
- Keysight Technologies extends collaboration with Synopsys
- 08/03/22
- Keysight, Nokia collaborate on public 800GE test
- 07/29/22
- The Digital IF Interoperability Consortium announces seven new members
- 07/13/22
- AI-LINK selects Keysight's 5G test tools for performance validation
- 08/15/22
- Keysight Technologies extends collaboration with Synopsys
- 06/22/22
- Synopsys sees WhiteHat Security acquisition neutral to FY22 adjusted EPS
- 05/27/22
- Synopsys initiates $200M ASR with Wells Fargo
- 05/24/22
- Synopsys enters distribution agreement with Arrow Electronics
- 14:37 Today
- Bluebird Bio confirms Zynteglo wholesale acquisition cost of $2.8M
- 14:30 Today
- Bluebird Bio trading resumes
- 14:12 Today
- Bluebird Bio to resume trading at 2:30 pm ET
- 14:08 Today
- Bluebird Bio confirms FDA approval of Zynteglo
- 17:09 Today
- Phillips 66 proposing consideration of $34.75 per unit of DCP Midstream
- 17:05 Today
- Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31%
- 08/01/22
- DCP Midstream releases annual Sustainability Report
- 07/19/22
- DCP Midstream raises Q2 cash distribution 10% to 43c per unit
- 16:25 Today
- Bath & Body Works saw declines in traffic trends in June, first part of July
- 16:24 Today
- Bath & Body Works recently cut 130 roles in home office organization
- 05/19/22
- Bath & Body Works sees FY inflation impact $225M-$250M
- 05/19/22
- Bath & Body Works to test new personal care line, including face and hair care
AXDX Accelerate Diagnostics - 07/11/22
- Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc
- 05/16/22
- Accelerate Diagnostics begins commercialization of Accelerate Arc system
- 04/25/22
- Accelerate Diagnostics' Arc System kit shows sample accuracy in studies
- 06/01/22
- QuickLogic awarded new $3.0M eFPGA contract
- 03/30/22
- QuickLogic wins new $1.5M eFPGA contract
- 03/10/22
- QuickLogic wins new eFPGA contract for approximately $1M
- 16:59 Today
- Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY
- 16:44 Today
- RC Ventures files to sell Bed Bath & Beyond stake
- 10:03 Today
- Bed Bath & Beyond trading resumes
- 09:58 Today
- Bed Bath & Beyond trading halted, volatility trading pause
- 16:59 Today
- Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY
- 08/16/22
- GameStop trading resumes
- 08/16/22
- GameStop trading halted, volatility trading pause
- 08/08/22
- GameStop trading resumes
- 16:59 Today
- Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY
- 10:00 Today
- Blue Apron rises 10.6%
- 09:47 Today
- Blue Apron rises 22.5%
- 08:51 Today
- Blue Apron up 24% at $6.67 in pre-market trading
- 16:59 Today
- Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY
- 08/16/22
- FuboTV rises 20.1%
- 08/11/22
- FuboTV adds SportsGrid network
- 08/08/22
- FuboTV rises 14.1%
- 17:20 Today
- Cineworld evaluates strategic options amid slow attendance, limited film slate
- 08/08/22
- AMC Entertainment rises 16.9%
- 08/08/22
- AMC Entertainment trading resumes
- 08/08/22
- AMC Entertainment trading halted, volatility trading pause
- 08/15/22 Piper Sandler
- ON Semiconductor price target raised to $90 from $75 at Piper Sandler
- 07/14/22 JPMorgan
- Wolfspeed price target lowered to $80 from $105 at JPMorgan
- 06/29/22 BofA
- Wolfspeed price target lowered to $75 from $95 at BofA
- 06/23/22 Goldman Sachs
- Wolfspeed upgraded to Buy from Neutral at Goldman Sachs
- 08/15/22 Citi
- Cisco to trade lower due to valuation multiple compression, says Citi
- 08/02/22 Citi
- Arista Networks price target raised to $170 from $160 at Citi
- 07/15/22 KGI Securities
- Cisco downgraded to Neutral from Outperform at KGI Securities
- 07/14/22 JPMorgan
- Cisco downgraded to Neutral from Overweight at JPMorgan
KEYS Keysight Technologies - 08/09/22 Deutsche Bank
- Keysight Technologies price target raised to $190 from $176 at Deutsche Bank
- 07/14/22 JPMorgan
- Keysight Technologies price target lowered to $176 from $200 at JPMorgan
- 06/17/22 UBS
- Keysight Technologies price target lowered to $177 from $220 at UBS
- 06/01/22 Goldman Sachs
- Keysight Technologies price target lowered to $165 from $185 at Goldman Sachs
- 08/16/22 Wolfe Research
- Synopsys initiated with an Outperform at Wolfe Research
- 08/11/22 Wells Fargo
- Synopsys price target raised to $425 from $375 at Wells Fargo
- 06/29/22 BofA
- Synopsys upgraded to Neutral from Underperform at BofA
- 05/19/22 Needham
- Synopsys price target raised to $380 from $370 at Needham
- 15:37 Today BTIG
- Bluebird's approval has positive read for Mustang Bio, says BTIG
- 15:35 Today Piper Sandler
- Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel
- 08/05/22 Barclays
- Barclays upgrades Bluebird Bio to Equal Weight, raises price target to $5
- 08/05/22 Barclays
- Bluebird Bio upgraded to Equal Weight from Underweight at Barclays
- 08/16/22 Barclays
- DCP Midstream price target raised to $40 from $38 at Barclays
- 07/20/22 Barclays
- DCP Midstream price target lowered to $38 from $43 at Barclays
- 07/12/22 RBC Capital
- DCP Midstream upgraded to Outperform from Sector Perform at RBC Capital
- 06/13/22 Raymond James
- DCP Midstream added to Analyst Current Favorites list at Raymond James
- 08/16/22 B. Riley
- Bath & Body Works price target raised to $48 from $44 at B. Riley
- 07/25/22 Barclays
- Bath & Body Works price target lowered to $33 from $40 at Barclays
- 07/21/22 Deutsche Bank
- Bath & Body Works price target lowered to $41 from $61 at Deutsche Bank
- 07/21/22 B. Riley
- Bath & Body risk/reward attractive despite guidance cut, says B. Riley
AXDX Accelerate Diagnostics - 03/09/22 Craig-Hallum
- Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5
- 03/09/22 Craig-Hallum
- Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum
- 01/14/22 Craig-Hallum
- Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum
- 11/18/21 Roth Capital
- QuickLogic price target raised to $12 from $8 at Roth Capital
- 08/16/22 Odeon Capital
- Odeon Capital downgrades Bed Bath & Beyond to Sell with $7.50 price target
- 08/16/22 Odeon Capital
- Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 08/16/22 B. Riley
- Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 07/22/22 Wedbush
- GameStop price target lowered to $7.50 from $30 at Wedbush
- 05/26/22 Wedbush
- Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
- 03/28/22 B. Riley
- Bed Bath & Beyond price target raised to $26 from $19 at B. Riley
- 08/10/22 Lake Street
- Blue Apron initiated with a Buy at Lake Street
- 07/20/22 Benchmark
- Benchmark starts Blue Apron at Buy with turnaround not getting credit
- 07/20/22 Benchmark
- Blue Apron initiated with a Buy at Benchmark
- 05/10/22 Canaccord
- Blue Apron price target lowered to $10 from $12 at Canaccord
- 08:22 Today Evercore ISI
- FuboTV price target raised to $8 from $5 at Evercore ISI
- 07:56 Today Stephens
- Stephens sees no major news from FuboTV analyst day to justify 'short squeeze'
- 06:51 Today Wedbush
- Wedbush downgrades FuboTV to Neutral, raises price target to $6
- 06:16 Today Wedbush
- FuboTV downgraded to Neutral from Outperform at Wedbush
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 07/07/22 Citi
- AMC Entertainment price target lowered to $5 from $6 at Citi
- 06/21/22 B. Riley
- AMC Entertainment price target lowered to $11 from $16 at B. Riley
- 06/06/22 Citi
- AMC Entertainment shares remain overvalued, says Citi
- 16:07 Today
- Wolfspeed sees Q1 EPS (8c) to (2c), consensus (7c)
- 16:06 Today
- Wolfspeed reports Q4 EPS (2c), consensus (10c)
- 05/04/22
- Wolfspeed sees Q4 adjusted EPS (13c)-(7c), consensus (12c)
- 05/04/22
- Wolfspeed reports Q3 adjusted EPS (12c), consensus (14c)
- 16:07 Today
- Cisco sees FY23 adjusted EPS $3.49-$3.56, consensus $3.53
- 16:06 Today
- Cisco sees Q1 adjusted EPS 82c-84c, consensus 84c
- 16:05 Today
- Cisco reports Q4 adjusted EPS 83c, consensus 82c
- 13:20 Today
- Notable companies reporting after market close
KEYS Keysight Technologies - 16:06 Today
- Keysight Technologies sees Q4 adjusted EPS $1.94-$2.00, consensus $1.89
- 16:06 Today
- Keysight Technologies reports Q3 adjusted EPS $2.01, consensus $1.78
- 05/17/22
- Keysight Technologies sees FY22 EPS up 14%-15%, consensus $7.01
- 05/17/22
- Keysight Technologies sees Q3 EPS $1.74-$1.80, consensus $1.75
- 16:12 Today
- Synopsys sees Q4 non-GAAP EPS $1.06-$1.18, consensus $1.73
- 16:11 Today
- Synopsys raises FY22 non-GAAP EPS view to $8.80-$8.85 from $7.85-$7.92
- 16:07 Today
- Synopsys reports Q3 non-GAAP EPS $2.10 vs $1.81 a year ago
- 13:20 Today
- Notable companies reporting after market close
- 08/04/22
- Bluebird Bio reports Q2 EPS ($1.36), consensus ($1.24)
- 05/09/22
- Bluebird Bio reports Q1 EPS ($1.66), consensus ($1.39)
- 03/04/22
- Bluebird Bio reports Q4 EPS ($2.14), consensus ($1.88)
- 08/02/22
- DCP Midstream reports Q2 EPS $1.77, consensus $1.13
- 05/04/22
- DCP Midstream reports Q1 EPS 32c, may not compare to consensus 99c
- 16:28 Today
- Bath & Body Works sees FY revenue down mid to high single digits vs. last year
- 16:26 Today
- Bath & Body Works sees Q3 sales down mid to high single digits vs. last year
- 16:21 Today
- Bath & Body Works sees FY22 EPS $2.70-$3.00, consensus $2.92
- 16:18 Today
- Bath & Body Works sees Q3 EPS 10c-20c, consensus 31c
AXDX Accelerate Diagnostics - 05/16/22
- Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c)
- 03/08/22
- Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c)
- 08/16/22
- QuickLogic reports Q2 non-GAAP EPS 0c, consensus (4c)
- 06/01/22
- QuickLogic backs Q2 revenue view $4.5M, consensus $4.47M
- 05/17/22
- QuickLogic reports Q1 adjusted EPS (6c), consensus (7c)
- 06/29/22
- Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39)
- 06/28/22
- Notable companies reporting before tomorrow's open
- 06/28/22
- Notable companies reporting before tomorrow's open
- 04/13/22
- Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c
- 06/01/22
- GameStop reports Q1 EPS ($2.08), consensus ($1.45)
- 06/01/22
- Notable companies reporting after market close
- 03/17/22
- GameStop reports Q4 EPS ($1.94) vs $1.19 last year
- 03/17/22
- Notable companies reporting after market close
- 08/08/22
- Blue Apron cuts FY22 revenue growth view to 7%-13% vs. mid-teens
- 08/08/22
- Blue Apron reports Q2 EPS (68c) vs. (98c) a year ago
- 05/10/22
- Blue Apron targets revenue of $700M-plus in 2024
- 05/09/22
- Blue Apron sees FY revenue growth in mid teens, one est. $532.3M
- 08/04/22
- FuboTV reports Q2 EPS (45c), consensus (69c)
- 05/05/22
- FuboTV reports Q1 EPS (69c), consensus (65c)
- 05/05/22
- Notable companies reporting after market close
- 02/23/22
- FuboTV reports Q4 EPS (57c), consensus (67c)
- 08/04/22
- AMC Entertainment reports Q2 adjusted EPS (20c), consensus (19c)
- 05/09/22
- AMC Entertainment reports Q1 adjusted EPS (52c), consensus (63c)
- 05/09/22
- Notable companies reporting after market close
- 05/05/22
- Hycroft Mining reports Q1 EPS (27c) vs. (16c) last year
- 06/23/22
- Cisco, Nike planning to fully exit Russia, Reuters reports
- 06/23/22
- Cisco to begin 'orderly wind-down' of Russia business, Reuters reports
- 06/06/22
- CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports
- 04/13/22
- Synopsys probed by Commerce Department over China, Bloomberg reports
- 04/13/22
- Synopsys sent subpoena from Commerce Department on China, Blomberg says
- 13:55 Today
- Bluebird Bio to charge $2.8M for Zynteglo treatment, Bloomberg says
- 06/10/22
- FDA votes 13-0 in support of Bluebird Bio's Beti-Cel, Bloomberg reports
- 06/09/22
- FDA panel: Bluebird Bio's Eli-Cel benefits outweigh risks, BioPharmaDrive says
- 16:35 Today
- RC Ventures files to sell entire Bed Bath & Beyond stake, Bloomberg says
- 08/13/22
- Royal Caribbean among companies at risk of liquidity squeeze, Barron's says
- 08/03/22
- Bed Bath & Beyond weighing private loans, Bloomberg reports
- 08/03/22
- Bed Bath & Beyond in talks with private credit providers, Bloomberg says
- 08/13/22
- Coinbase looking more like a meme stock, Barron's says
- 07/21/22
- Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says
- 07/07/22
- GameStop CFO Mike Recupero replaced by Diana Jajeh, Axios says
- 07/07/22
- GameStop CFO out, company making layoffs, Axios says
- 05/10/22
- Blue Apron shares going to $10 unless management 'sociopaths,' Citrons says
- 08/15/22
- Summer movies show audiences, studio chiefs committed to theaters, WSJ reports
- 08/13/22
- Coinbase looking more like a meme stock, Barron's says
- 07/11/22
- U.S. box office sales rising closer to pre-pandemic levels, CNBC reports
- 07/22/22
- Sell these stocks now, proven algorithm says
- 07/15/22
- Sell these stocks now, proven algorithm says
- 07/08/22
- Sell these stocks now, proven algorithm says
- 06/24/22
- What You Missed On Wall Street On Friday
- 12:15 Today
- Here's what Wall Street experts are saying about Cisco ahead of earnings
- 06/23/22
- What You Missed On Wall Street On Thursday
- 06/23/22
- What You Missed On Wall Street This Morning
- 05/19/22
- What You Missed On Wall Street On Thursday
KEYS Keysight Technologies - 03/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/19/22
- Fly Intel: Pre-market Movers
- 05/18/22
- Fly Intel: After-Hours Movers
- 04/13/22
- What You Missed On Wall Street On Wednesday
- 16:24 Today
- What You Missed On Wall Street On Wednesday
- 08/02/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 06/13/22
- What You Missed On Wall Street On Monday
- 06/13/22
- Fly Intel: Pre-market Movers
- 07/20/22
- What You Missed On Wall Street On Wednesday
- 07/20/22
- What You Missed On Wall Street This Morning
- 07/20/22
- Fly Intel: Pre-market Movers
- 06/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/17/22
- Fly Intel: After-Hours Movers
- 08/16/22
- Fly Intel: After-Hours Movers
- 08/16/22
- What You Missed On Wall Street On Tuesday
- 08/16/22
- What You Missed On Wall Street This Morning
- 08/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/12/22
- Short Report: Bed Bath Beyond shorts nudge higher as stock soars
- 08/09/22
- What You Missed This Week in Video Games
- 08/06/22
- Opening Day: Magic Empire opening surge calls to mind AMTD Digital frenzy
- 08/03/22
- Citron says AMTD Digital ‘NOT a meme stock’ despite massive rise in shares
- 08/12/22
- Short Report: Bed Bath Beyond shorts nudge higher as stock soars
- 08/10/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 06/04/22
- Short Report: GameStop short position reaches 15-month high
- 06/01/22
- Fly Intel: After-Hours Movers
- 12:03 Today
- What You Missed On Wall Street This Morning
- 09:59 Today
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/12/22
- Bet On It: Massachusetts betting bill signed into law ahead of NFL season
- 05/13/22
- Short Report: Upstart shorts take profits as stock craters on guidance cut
- 08/15/22
- What You Missed On Wall Street This Morning
- 08/05/22
- Fly Intel: Pre-market Movers
- 08/04/22
- Fly Intel: After-Hours Movers
- 07/15/22
- Sell these stocks now, proven algorithm says
- 13:49 Today
- Wolfspeed options imply 9.5% move in share price post-earnings
- 13:04 Today
- Cisco options imply 4.7% move in share price post-earnings
- 06/28/22
- Cisco put volume heavy and directionally bearish
- 06/10/22
- Cisco put volume heavy and directionally bearish
- 05/20/22
- Notable open interest changes for May 20th
- 14:04 Today
- Synopsys options imply 4.0% move in share price post-earnings
- 05/19/22
- Early notable gainers among liquid option names on May 19th
- 08/12/22
- Bluebird Bio call volume above normal and directionally bullish
- 08/11/22
- Bluebird Bio call volume above normal and directionally bullish
- 08/08/22
- Bluebird Bio call volume above normal and directionally bullish
- 08/05/22
- Bluebird Bio call volume above normal and directionally bullish
- 13:19 Today
- Bath & Body Works options imply 7.3% move in share price post-earnings
- 08/16/22
- Early notable gainers among liquid option names on August 16th
- 07/20/22
- Bath & Body Works put volume heavy and directionally bearish
- 07/06/22
- Bath & Body Works put volume heavy and directionally bearish
- 08:55 Today
- Notable open interest changes for August 17th
- 08/16/22
- Bed Bath & Beyond call volume above normal and directionally bullish
- 08/16/22
- Notable open interest changes for August 16th
- 08/15/22
- Unusually active option classes on open August 15th
- 08/16/22
- GameStop call volume above normal and directionally bullish
- 08/08/22
- GameStop call volume above normal and directionally bullish
- 07/25/22
- Notable open interest changes for July 25th
- 07/22/22
- Unusually active option classes on open July 22nd
- 09:40 Today
- Unusually active option classes on open August 17th
- 08/16/22
- Blue Apron call volume above normal and directionally bullish
- 08/15/22
- Unusually active option classes on open August 15th
- 07/07/22
- Largest borrow rate increases among liquid names
- 08:55 Today
- Notable open interest changes for August 17th
- 08/16/22
- fuboTV call volume above normal and directionally bullish
- 08/03/22
- Unusually active option classes on open August 3rd
- 07/15/22
- Largest borrow rate increases among liquid names
- 08/09/22
- Notable open interest changes for August 9th
- 08/08/22
- Notable open interest changes for August 8th
- 08/05/22
- Notable open interest changes for August 5th
- 08/04/22
- AMC Entertainment options imply 11.7% move in share price post-earnings
|
|
Syndicate
| ShowHide Related Items >><< AXDX Accelerate Diagnostics - 07/11/22
- Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc
- 05/16/22
- Accelerate Diagnostics begins commercialization of Accelerate Arc system
- 04/25/22
- Accelerate Diagnostics' Arc System kit shows sample accuracy in studies
AXDX Accelerate Diagnostics - 03/09/22 Craig-Hallum
- Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5
- 03/09/22 Craig-Hallum
- Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum
- 01/14/22 Craig-Hallum
- Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum
AXDX Accelerate Diagnostics - 05/16/22
- Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c)
- 03/08/22
- Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c)
|
|
Hot Stocks
| ShowHide Related Items >><< - 07/15/22
- SeaChange chairman Robert Pons resigns, Peter Aquino named chairman
- 06/14/22
- Trillerverz, SeaChange agree to mutually terminate proposed merger
- 06/14/22
- SeaChange, Triller mutually agree to terminate proposed merger agreement
- 04/04/22
- SeaChange, VIDAA partner to develop streaming, ad insertion solution
- 04/08/22
- SeaChange reports Q4 adjusted EPS 2c vs. (9c) last year
- 07/30/22
- Opening Day: Immune-oncology company MAIA Biotechnology drops in market debut
- 07/16/22
- Opening Day: AMTD Digital soars in trading debut
- 07/02/22
- Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO
|
|
Hot Stocks
| ShowHide Related Items >><< VRTX Vertex Pharmaceuticals - 08/04/22
- Vertex Pharmaceuticals raises FY22 product revenue view to $8.6B-$8.8B
- 07/22/22
- Vertex Pharmaceuticals plans to advance VX-548 into Phase 3 clinical trials
- 07/20/22
- Vertex Pharmaceuticals, Verve Therapeutics enter exclusive research pact
- 07/11/22
- Vertex Pharmaceuticals to acquire ViaCyte for $320M in cash
VRTX Vertex Pharmaceuticals - 15:35 Today Piper Sandler
- Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel
- 08/16/22 Piper Sandler
- Vertex Pharmaceuticals price target raised to $288 from $256 at Piper Sandler
- 08/05/22 Truist
- Global Blood could complement any oncology franchise, says Truist
- 08/05/22 H.C. Wainwright
- Vertex Pharmaceuticals price target raised to $300 from $275 at H.C. Wainwright
VRTX Vertex Pharmaceuticals - 08/04/22
- Vertex Pharmaceuticals reports Q2 adjusted EPS $3.60, consensus $3.48
- 05/05/22
- Vertex Pharmaceuticals reports Q1 adjusted EPS $3.52, consensus $3.49
- 05/05/22
- Notable companies reporting after market close
VRTX Vertex Pharmaceuticals - 06/01/22
- What You Missed On Wall Street On Wednesday
- 06/01/22
- What You Missed On Wall Street This Morning
- 06/01/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/23/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
VRTX Vertex Pharmaceuticals - 07/05/22
- Early notable gainers among liquid option names on July 5th
|
|
Hot Stocks
| ShowHide Related Items >><< ORC Orchid Island Capital - 04/13/22
- Orchid Island Capital estimates book value per share of $3.34 as of March 31
ORC Orchid Island Capital - 08/08/22 Ladenburg
- Orchid Island downgraded on expected dividend cut at Ladenburg
- 08/08/22 Ladenburg
- Orchid Island Capital downgraded to Neutral from Buy at Ladenburg
- 02/25/22 JonesTrading
- Orchid Island downgraded on book value drop-off at JonesTrading
- 02/25/22 JonesTrading
- Orchid Island Capital downgraded to Hold from Buy at JonesTrading
ORC Orchid Island Capital - 07/13/22
- Orchid Island Capital sees Q2 EPS (34c), consensus 18c
- 02/24/22
- Orchid Island Capital reports Q4 EPS (27c), consensus 23c
|
|
Hot Stocks
| ShowHide Related Items >><< - 08/15/22
- Plus Therapeutics announces $2M share repurchase program
- 08/14/22
- Plus Therapeutics presents data from Ongoing ReSPECT trials
- 08/13/22
- Plus Therapeutics presents data from Oongoing ReSPECT clinical trials
- 07/12/22
- Plus Therapeutics completes key milestone on path to commercialize 186RNL
- 07/22/22 H.C. Wainwright
- Plus Therapeutics price target lowered to $3.50 from $7 at H.C. Wainwright
|
